Emzahh Gets FDA Approval for Pregnancy Prevention
Emzahh is an AB-rated generic equivalent of Ortho Micronor.
Diagnosis & Disease Information
Reforming Institutions, Integrating Health Technology to Address Maternal Mortality Gap
Experts discuss strategies to reduce the maternal mortality gap by implementing implicit bias training and reevaluating clinical guidelines and algorithms.
Older Age, Prior AMR Risk Factors for Adverse Outcomes in Uncomplicated UTI
Researchers assessed whether adverse outcomes in women with uncomplicated UTI are more likely when initial antibiotic therapy does not cover the causative uropathogen.
ACP Recommends Bisphosphonates for Initial Treatment of Osteoporosis
The American College of Physicians updated its 2017 guideline on pharmacologic treatment of osteoporosis or low bone mass to prevent fractures in adults.
Low-Molecular-Weight Heparin for Thromboprophylaxis in Pregnancy: What Dose Is Best?
Researchers evaluated the efficacy and safety of intermediate-dose vs low-dose low-molecular-weight heparin in pregnant women with a history of venous thromboembolism.
Benzodiazepine Prenatal Exposure No Risk for Autism Spectrum Disorder and ADHD
Is prenatal benzodiazepine exposure associated with increased risks for autism spectrum disorder or attention-deficit/hyperactivity disorder?
Maternal Mortality Crisis Among Minority Patients in the US
ACOG experts provide actionable steps to reduce the maternal mortality crisis in the US, particularly among minority populations.
FDA Approves Brexafemme for Recurrent Vulvovaginal Candidiasis
Brexafemme is an oral antifungal agent representing a novel therapeutic class of structurally-distinct glucan synthase inhibitors known as triterpenoids.
Zejula Use for Second-Line Maintenance Treatment Restricted
The decision to restrict the indication follows an FDA review of the double-blind, placebo-controlled phase 3 ENGOT-OV16/NOVA trial.
Elahere Granted Accelerated Approval for Platinum-Resistant Ovarian Cancer
The approval was based on data from the SORAYA trial.
- Loading...
Loading...
Next post in Oncology
Loading... 
Loading...